பூமி பரிசோதனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பூமி பரிசோதனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பூமி பரிசோதனை Today - Breaking & Trending Today

Blue Earth Diagnostics Announces Axumin® (Fluciclovine F 18) Presentations at Upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

Blue Earth Diagnostics Announces Axumin® (Fluciclovine F 18) Presentations at Upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Emily Steinberger Weg , Bridgetf Koontz , Rachel Kang , Todd Yezefski , Danielw Lin , Danielh Shevrin , Michael Anthony Carducci , Davida Mankoff , Nathan Conrad , Georgina Mowatt , Yu Hui Chen , Neha Vapiwala , Jing Zeng , Priscilla Harlan , Axumin Fluciclovine , Delphinel Chen , Glenn Liu , Evany Yu , Volkan Beylergil , Andrea Toulouse , Risa Liang Wong , Fenghai Duan , Sarahk Holt , Andrew Caleb Hsieh ,

Results Published for Axumin (Fluciclovine F 18) PET Imaging Study Demonstrating Improved Patient Outcomes in Patients with Recurrent Prostate Cancer


Results Published for Axumin (Fluciclovine F 18) PET Imaging Study Demonstrating Improved Patient Outcomes in Patients with Recurrent Prostate Cancer
Treatment informed by Axumin PET imaging significantly improved event-free-survival for men with recurrent prostate cancer at three and four years
May 25, 2021   Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, is pleased to share news of the publication of a study from researchers at Winship Cancer Institute of Emory University (Winship) evaluating Axumin (fluciclovine F 18) PET imaging in men with recurrent prostate cancer. The randomized, prospective study showed that Axumin-guided post-prostatectomy radiation therapy increased biochemical event-free survival rates in men with recurrent disease. Among 165 patients whose prostate cancer had returned following surgical removal of their prostate, 75.5% whose treatment integrated ....

United States , Emory University , Karenm Xu , Eduard Schreibmann , Davidm Schuster , Omer Kucuk , David Gauden , Josephw Shelton , Mehmeta Bilen , Asheshb Jani , Bradley Carthon , Olayinkaa Abiodun Ojo , Preteshr Patel , Mark Goodman , Sherrie Cooper , Bruce Hershatter , Peterj Rossi , Shreyass Joshi , Subir Goyal , Raghuveer Halkar , Winship Cancer Institute Of Emory University , Blue Earth Diagnostics , Winship Cancer Institute , Randomized Trial Comparing , Prostate Cancer , Emory Molecular Prostate Imaging ,